Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Murine therapeutic models for Charcot-Marie-Tooth (CMT) disease.
Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study.
Methylene blue alleviates experimental autoimmune encephalomyelitis by modulating AMPK/SIRT1 signaling pathway and Th17/Treg immune response.
Chemical exchange saturation transfer of the cervical spinal cord at 7 T.
B cell-derived transforming growth factor-β1 expression limits the induction phase of autoimmune neuroinflammation.
Emery-Dreifuss muscular dystrophy type 2 associated (?) with mild peripheral polyneuropathy.
Osmotic demyelination syndrome complicating diabetes with anti-glutamic acid decarboxylase antibodies and Graves' disease: A case report.
Advances in biomarker research in multiple sclerosis.
Cytokine Profile in Patients with Progressive Multiple Sclerosis and Its Association with Disease Progression and Disability.
Relapses in multiple sclerosis: Relationship to disability.
NADPH oxidase 2 (NOX2) enzyme activation in patients with chronic inflammatory demyelinating polyneuropathy.
Effects of vitamin D on the peripheral adaptive immune system: a review.
Clinical and demographical characteristics of primary progressive multiple sclerosis in Isfahan, Iran.
A review of genome-wide association studies for multiple sclerosis: classical and hypothesis-driven approaches.
Similar Effects Seen for Fingolimod, Placebo in Primary Progressive Multiple Sclerosis
Targeting specific cells in the brain with nanomedicines for CNS therapies.
Fatigue predicts disease worsening in relapsing-remitting multiple sclerosis patients.
Effect of integrated Yoga and Physical therapy on audiovisual reaction time, anxiety and depression in patients with chronic multiple sclerosis: a pilot study.
Spinal Cord in Multiple Sclerosis: Magnetic Resonance Imaging Features and Differential Diagnosis.
Splenic Marginal Zone Lymphoma: An indolent malignancy leading to the development of neurolymphomatosis.
Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.
Serum and CSF GQ1b antibodies in isolated ophthalmologic syndromes.
Event-related potentials and cognitive performance in multiple sclerosis patients with fatigue.
Modeling The Natural History of Secondary-Progressive Multiple Sclerosis: A New Modeling Approach Using Discrete Event Simulation.
NCF1 gene and pseudogene pattern: association with parasitic infection and autoimmunity.

Pages